Adipocyte membranes from control rats exhibited a functional Gi (inhibitory guanine-nucleotide-binding protein) activity which could be assessed either by the inhibitory action of low concentrations of guanosine 5-[/Jy-imido]triphosphate (p[NH]ppG) upon forskolin-stimulated adenylate cyclase activity or by the inhibitory action of high concentrations of GTP upon isoprenaline-stimulated adenylate cyclase activity. When membranes from animals made diabetic with streptozotocin were used, then both such inhibitory functions of Gi were abolished. In contrast, receptor-mediated inhibitory responses of G1, effected by N6-phenylisopropyl (adenosine), prostaglandin E2or nicotinate, were either unchanged or even apparently more effective in membranes from diabetic animals. Induction of diabetes did not cause any change in the adipocyte plasma membrane levels of the a, GTP-binding subunits of either Gil or Gi2 or of G.
INTRODUCTION
Adenylate cyclase is a key regulatory enzyme which transduces the action of many hormones in a variety of target cells. The receptors which determine its function can exert stimulatory or inhibitory effects on this enzyme depending upon whether they are coupled to stimulatory (G.) or inhibitory (G1) guanine-nucleotide-binding regulatory proteins [1] [2] [3] [4] .
We have proposed [5, 6] that changes in Gi functioning may occur in insulin-resistant states that characterize some forms of diabetes and obesity. This was based upon our observations that in rats made acutely diabetic by treatment with streptozotocin, there followed a loss of functional G. activity, as assessed by using the nonhydrolysable GTP analogue p[NH]ppG (guanosine 5'- [fiy-imido]triphosphate), both in purified liver plasma membranes and in hepatocyte membranes [6] . Such a loss of functional Gi was originally attributed entirely to a loss of protein [6] , although recent evidence has suggested to us that any residual G, is inactivated [7] .
Indeed, we have shown [5] that whereas G. is expressed in hepatocyte membranes from both lean and obese Zucker rats, only in the lean animals is it functional.
Hepatocytes have a P2-purinergic receptor which couples to Gi [8] . As 
Preparation of membranes
Rats were killed by cervical dislocation and white epididymal fat pads removed. Adipocytes were prepared according to the method of Rodbell [10] . Isolated adipocytes were suspended in 4 ml of buffered sucrose (0.25 M-sucrose/5 mM-Tris/HCI/3 mM-ATP, pH 7.4)/g of original tissue, at a temperature of 20-25°C, and hand homogenized in a Potter-Elvejhem homogeniser (10 strokes). The resulting homogenate was then centrifuged at 1500 g for 5 min at 4°C, the fat cake was removed and the supernatant was subjected to centrifugation at 15000 g for 15 min at 4 'C. The pellet was resuspended in buffered sucrose, by five strokes of a hand-operated Potter-Elvejhem homogenizer, and centrifuged at 15 000 g for 15 min at 4 'C. The resulting pellet was resuspended in 1 mM-EDTA/1 mM-Tris/HCl, pH 7.4, to concentrations of approx 1-2 mg/ml and frozen rapidly to -80 'C. Membranes stored at this temperature retained full activity for at least 8 weeks.
Assay of adenylate cyclase
This was done essentially as described by Heyworth & Houslay [11] . Briefly, the reaction conditions employed the use of a medium containing 5 mM-MgSO4, 10 mMtheophylline, 1 mM-EDTA, 22 mM-disodium phosphocreatine, 1.0 mM-ATP, 1 mM-dithiothreitol, 1 
Immunoblotting of membranes
The specific antisera to the gene products of the asubunits of the 'G, '-like genes and the procedures employed to analyse adipocyte membranes have been detailed before by us. [12] . Antiserum AS7 was used to detect the a-subunits of Gil and G,2, and antiserum 13B was used to detect the a-subunit of Gi3. Antiserum CS1, which was generated against the C-terminal decapeptide of a-Gs, was used to detect the 42 kDa and 45 kDa forms of a-Gs. for 3 h and then removed and washed as above before the addition of O-dianisidine hydrochloride as the detection system. In some experiments "25I-labelled second antisera were used. Detection of the coloured product of the O-dianisidine was done as described before [6] and for the 125I second antibody it was achieved by locating labelled species with autoradiography followed either by densitometric scanning or by excising the radioactive bands from the nitrocellulose and counting the radioactivity in a gamma counter. We estimated that our minimum level of detection of G-protein a-subunits was 0.25 pmol per track, and that linear relationships held for additions of adipocyte membranes to gel tracks of between 40 and 200 ,ag/track.
RESULTS AND DISCUSSION
It is now well established that, in membranes from adipocytes, hepatocytes and various other tissues, the Gproteins Gs and Gi exhibit very different affinities for guanine nucleotides [1] [2] [3] [4] . This has allowed the experimental detection of Gi function by selective activation using appropriate concentrations of either GTP or p[NH]ppG [13] [14] [15] . Thus, after amplifying basal adenylate cyclase activity using the diterpene forskolin, low concentrations of p[NH]ppG cause the dose-dependent inhibition of adenylate cyclase activity through The fact that PIA appears to show an enhanced inhibitory effect in membranes from diabetic animals ( Table 2) is probably due to the fact that inhibition of adenylate cyclase mediated by GTP alone is abolished in diabetic membranes, whereas this is not the case in membranes from normal animals. Thus PIA, in the presence of GTP, has a greater apparent inhibitory effect. Indeed, the GTP-dependence of the inhibitory action of PIA can be seen clearly in membranes from diabetic animals (Fig. 3b) . Thus we see that, in the presence of PIA (Fig. 3b) , but not in its absence (Fig. 2b) , elevated GTP concentrations do indeed lead to PIAmediated inhibition of adenylate cyclase activity.
We also noted that the ability of isoprenaline to stimulate adenylate cyclase activity in membranes from diabetic animals was enhanced in comparison with that found in membranes from non-diabetic controls (Table  1) . Such an observation has been made for both the isoprenaline- [17] and glucagon- [15] mediated stimulation of adenylate cyclase activity in membranes from normal animals whose cells were pretreated with pertussis toxin in order to inactivate Gi before assay. The heightened response employing diabetic membranes was not due to any increase in the amount of the stimulatory G-protein, G5, as the induction of the diabetes did not affect the amount of the two forms [45 kDa (G.') and 42 kDa (Gj); [1] of a-G. subunits (Fig. 4) . Thus levels of a-G.' and -G5 in membranes from diabetic animals differed by some 6 + 5 % and -7 + 6 % respectively from those seen using membranes from control animals (six different animals). We believe, then, that inactivation of the GTP-stimulation functioning of Gi in diabetic states removes a tonic inhibitory effect on receptor-Gsmediated activation of adenylate cyclase, which leads to enhanced stimulatory receptor responses.
We sought to ascertain whether these changes in Gi- Western blotting data are shown which were obtained using specific antisera to identify the a-subunits of forms of Gi and of Gs in adipocyte membranes as described before by us [12] . Track 1 contains membranes from control animals and track 2 from diabetic animals. In each instance identical amounts of membrane protein, from control and diabetic animals, were loaded on to the gels. mediated responses could be attributed to any alterations in the expression of the three forms of G, that are found in adipocytes [12] . Although the functional role of these various G-proteins has yet to be definitively ascertained, it has bien suggested that Gi2 might be the major species responsible for determining the inhibition of adenylate cyclase [18] . Certainly this would be consistent with our observations that Gi-mediated inhibition of adenylate cyclase is seen both in adipocytes, which express little G,3 [12] , and in hepatocytes [6, 16, 17] , which do not appear to express detectable levels of G, I (S. Griffiths, M. Bushfield & M. D. Houslay, unpublished work), whereas both cells express Gi2. In this study, we used the antiserum AS7 to detect both a-Gil (41 kDa) and a-G,2 (40 kDa) (Fig. 4) , which can be resolved by polyacrylamide-gel electrophoresis under appropriate conditions [12] . However, we found no evidence for differences in the apparent amounts of either of these two G-protein a-subunits in adipocyte membranes from normal and diabetic animals (Fig. 4) [19] [20] [21] . In such experiments, attempts to quantify a-G., using pertussistoxin-catalysed ADP-ribosylation, indicated similar levels of this G-protein in membranes from both the normal and diabetic littermates. Such experiments bear similarity to those described in this study and our previous investigations [5, 6] in highlighting a lesion in the inhibitory function of G1, rather than any loss of expression, in insulin-resistant states. Interestingly, however, Londos and co-workers [9] have refuted the work of Begin-Heick [20] , as they were unable to observe a loss of GTP-mediated inhibition of adenylate cyclase in adipocyte membranes from obese (ob/ob) mice. We believe that our study, however, offers an explanation for this discrepancy. This is because Londos and co-workers [9] performed their GTP dose-effect experiments in the presence of the adenosine analogue PIA, whereas BeginHeick [20] did not. Thus if the situation is analogous to that which we describe here, both investigators are correct. Begin-Heick [20] will have monitored the loss in the ability of' GTP-alone' to cause inhibition of adenylate cyclase, whereas Londos et al. [9] employed GTP to expose PIA-mediated inhibition. By analogy with what we describe here, it is possible to lose the first effect and not the second. Indeed, as here (Table 1 ) Londos and coworkers [9] also observed an enhanced ability of PIA to elicit inhibition in membranes from obese animals. Our observation that GTP-and receptor-mediated inhibitory functions of G. can be separated is not restricted to the modification of Gi seen in membranes from insulin-resistant states. Indeed, it has been shown [22] that the addition of high concentrations of NaCl (greater than 150 mM) can obliterate the inhibitory action of GTP while retaining and even amplifying that seen using PIA. It We have demonstrated recently [23] that the a-subunit of Gi can be phosphorylated by challenge of hepatocytes with hormones or agents that activate protein kinase C. This leads to the loss of ability of low concentrations of p[NH]ppG to inhibit forskolin-stimulated adenylate cyclase activity. Indeed, the a-subunit of Gi is now known to be a substrate not only for protein kinase C [23, 24] but also for protein kinase A [25] and the insulin receptor kinase [26, 27] . It is possible, therefore, that the lesion which leads to a change in functioning of Gi is its phosphorylation. We will show elsewhere (M. Bushfield & M. D. Houslay, unpublished work) that this occurs on a-Gi2 and that such a modification does not affect the ability of AS7 to either recognize or immunoprecipitate this G-protein. Indeed, one of us has suggested [28] that the protein kinase C-mediated phosphorylation of the insulin receptor and a-Gi may be key features of insulinresistant states [28, 29] .
